Udenafil - Wikipedia
网页Like other PDE 5 inhibitors, it is used to treat erectile dysfunction. Udenafil was developed by Dong-A Pharmaceutical. [1] It has fairly rapid onset of action (peak plasma concentration after 1 to 1.5 hours), and has long duration of action (plasma half-life of 11 to 13 hours).
Zudena (Udenafil) Informations
网页Udenafil is the generic name for the drug Zydena, which is used to treat erectile dysfunction in men. Dapoxetine, on the other hand, is used to treat premature ejaculation during sexual intercourse.
Udenafil: Uses, Interactions, Mechanism of Action - DrugBank …
网页2008年3月19日 · Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada. Type.
Understanding Zudena (Udenafil) – A Comprehensive Guide to Its …
网页Zudena, also known as Udenafil, is a PDE5 inhibitor medication used to treat erectile dysfunction (ED) in men. It works by increasing blood flow to the penis during sexual stimulation, helping men achieve and maintain an erection.
Udenafil: efficacy and tolerability in the management of erectile ...
网页Udenafil is a potent novel phosphodiesterase-5 inhibitor approved for use in Korea. Udenafil has unique properties, with a T max of 1.0–1.5 h and a T 1/2 of 11–13 h (a relatively rapid onset and a long duration of action). Therefore, both on-demand and once-daily use of udenafil have been reported.
Udenafil for the treatment of erectile dysfunction - PMC
网页2014年5月14日 · Udenafil can be an effective and well-tolerated treatment option for ED men with underlying HTN who take antihypertensive drugs.
Efficacy and Safety of Udenafil Once Daily in Patients with Erectile ...
网页2022年9月2日 · The daily use of 75 mg of udenafil, which has a high selectivity, was effective in PR without severe adverse effects in RP patients, a relatively elderly patient group. The peak plasma concentration of udenafil is achieved 0.8 to 1.3 hours after administration, and its half-life is 9.9 to 12.1 hours [ 11 , 36 ].
Efficacy and safety of udenafil for erectile dysfunction: a meta ...
网页The results from the current meta-analysis have suggested that udenafil is an effective and well-tolerated therapy for erectile dysfunction. The findings of the present review highlight the need for more efficient performance of higher quality, large-sample, various-race, long-term, randomized contr …
Efficacy and Safety of Udenafil for the ... - Clinical Therapeutics
网页Udenafil is an oral phosphodiesterase-5 inhibitor approved for the treatment of erectile dysfunction. In a multicenter, placebo-controlled, randomized Phase IIa study, the reduction of pulmonary vascular resistance index was greater with a 50-mg baseline dose of udenafil than with the 100-mg dose, the cardiac index did not decrease at most ...
Udenafil: What is it and is it FDA approved? - Drugs.com
网页2020年6月30日 · Generic name: udenafil. Company: Mezzion Pharma Co. Ltd. Treatment for: Single Ventricle Heart Disease. Udenafil is a long acting, highly selective phosphodiesterase-5 inhibitor in development for the treatment of patients who have undergone the Fontan operation for single ventricle heart disease.